Drug · DIN 02417219
KAZANO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 30, 2014; first marketed April 30, 2014.
- Drug Identification Number (DIN)
- 02417219
- Company (DIN owner)
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Metformin and alogliptin A10BD13
- Class
- Human
- Record last updated
- September 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ALOGLIPTIN (ALOGLIPTIN BENZOATE) | 12.5 MG | |
| METFORMIN HYDROCHLORIDE | 500 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 27, 2013: NOC 14955New Drug Submission (NDS)
Other DINs named KAZANO
- DIN 02417227 · Marketed
- DIN 02417235 · Marketed